PMV Pharmaceuticals, Inc. (PMVP) Stock

Healthcare · Biotechnology · Member of Other US Stocks

PMV Pharmaceuticals, Inc. (PMVP) closed at USD 1.29 on 2026-10-15, a change of -9.2 % over the past year, with a market capitalization of USD 91.37M.

PMV Pharmaceuticals, Inc. recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

PMV Pharmaceuticals, Inc. key figures

Previous close

USD 1.29 (2026-10-15)

1-year change

-9.2 %

Market cap

USD 91.37M

Enterprise value

USD -14.53M

P/E ratio (trailing)

-0.85

P/E ratio (forward)

-1.25

EPS (trailing)

-1.42

EPS (forward)

-0.97

PEG ratio

n/a

Price to book

0.91

Revenue growth

n/a

Earnings growth

n/a

Dividend per share (trailing)

0.00

Short ratio

2.67

Employees

54

Analyst consensus (third-party)

none

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About PMV Pharmaceuticals, Inc.

PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule therapies targeting p53 mutations and other p53-related cancers in the United States. It develops rezatapopt, a selective structural corrector of p53 Y220C mutations in Phase 2 clinical trials for tumor agnostic diseases. The company was formerly known as PJ Pharmaceuticals, Inc. and changed its name to PMV Pharmaceuticals, Inc. in July 2013. PMV Pharmaceuticals, Inc. was incorporated in 2013 and is headquartered in Princeton, New Jersey.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for PMV Pharmaceuticals, Inc. and compare it with other stocks.